HTDS (Hard to Treat Diseases) Other Income (Expense) : $ Mil (TTM As of . 20)

View and export this data going back to . Start your Free Trial

What is Hard to Treat Diseases Other Income (Expense)?

Hard to Treat Diseases's other income expense for the Hard to Treat Diseases's pretax income for the three months ended in . 20 was $0.00 Mil.

Hard to Treat Diseases Other Income (Expense) Historical Data

The historical data trend for Hard to Treat Diseases's Other Income (Expense) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hard to Treat Diseases Other Income (Expense) Chart

Hard to Treat Diseases Annual Data

Trend

Other Income (Expense)

Hard to Treat Diseases Quarterly Data

Other Income (Expense)

Hard to Treat Diseases Other Income (Expense) Calculation

Other income expense includes minority interest. Minority interest is a significant but non-controlling ownership of less than 50% of a company's voting shares by either an investor or another company.

Hard to Treat Diseases (OTCPK:HTDS) Other Income (Expense) Explanation

Minority interest is reported on the consolidated income statement as a share of profit belonging to minority shareholders.

Hard to Treat Diseases Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Hard to Treat Diseases Inc (OTCPK:HTDS) » Definitions » Other Income (Expense)

Comparable Companies

Traded in Other Exchanges

N/A

Address

2655 Ulmerton Road, No. 338, Clearwater, FL, USA, 33762

Website

http://www.htdsmedical.com

Hard to Treat Diseases Inc operates medical and cosmetics company in Europe, and Mainland China. It is s also in the process of developing its own stem cell bank.

Hard to Treat Diseases Headlines

No Headlines